Innospec (IOSP) Projected to Post Quarterly Earnings on Tuesday

Innospec (NASDAQ:IOSP) is anticipated to issue its Q4 2025 results after the market closes on Tuesday, February 17th. Analysts expect Innospec to post earnings of $1.26 per share and revenue of $460.8670 million for the quarter. Investors may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Wednesday, February 18, 2026 at 9:00 AM ET.

Innospec Price Performance

Shares of IOSP opened at $86.58 on Monday. Innospec has a 12 month low of $70.10 and a 12 month high of $112.74. The stock has a fifty day moving average price of $80.42 and a 200 day moving average price of $79.12. The company has a market cap of $2.15 billion, a P/E ratio of -2,886.00 and a beta of 0.91.

Wall Street Analysts Forecast Growth

IOSP has been the subject of several recent research reports. Wall Street Zen upgraded shares of Innospec from a “hold” rating to a “buy” rating in a research report on Saturday, December 13th. Zacks Research raised shares of Innospec from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 6th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Innospec in a research report on Monday, December 22nd. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce”.

Institutional Trading of Innospec

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. boosted its holdings in shares of Innospec by 71.6% in the fourth quarter. Goldman Sachs Group Inc. now owns 484,968 shares of the specialty chemicals company’s stock valued at $37,119,000 after acquiring an additional 202,325 shares in the last quarter. Millennium Management LLC lifted its position in Innospec by 8,176.5% in the first quarter. Millennium Management LLC now owns 170,414 shares of the specialty chemicals company’s stock worth $16,147,000 after purchasing an additional 168,355 shares during the period. Norges Bank bought a new position in Innospec during the 4th quarter valued at $10,654,000. Qube Research & Technologies Ltd increased its position in shares of Innospec by 72.1% during the 2nd quarter. Qube Research & Technologies Ltd now owns 306,761 shares of the specialty chemicals company’s stock valued at $25,796,000 after purchasing an additional 128,544 shares during the period. Finally, Victory Capital Management Inc. raised its stake in shares of Innospec by 13.7% in the 4th quarter. Victory Capital Management Inc. now owns 950,074 shares of the specialty chemicals company’s stock worth $72,719,000 after buying an additional 114,179 shares in the last quarter. 96.64% of the stock is currently owned by institutional investors.

Innospec Company Profile

Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.